London, May 18, 2026, 09:02 BST
Unilever PLC shares edged up in early London trade on Monday, outperforming a softer FTSE 100, as investors weighed buyout interest in its former ice-cream arm Magnum against a fresh bearish Jefferies note. The stock was quoted at 4,212 pence, up 0.12%, with 440,372 shares traded, while Reuters’ LSEG-delayed market data showed the FTSE 100 down 0.04% at 10,190.81.
This matters now because Unilever is no longer just being judged as a slow-moving consumer goods stock. The London-listed group has been reshaping itself around personal care, beauty and household brands, and it still owns 19.9% of Magnum, with plans to exit that stake within five years.
Reuters reported on Friday that Blackstone and Clayton, Dubilier & Rice were in the early stages of exploring bids for Magnum, owner of Ben & Jerry’s and Cornetto. The firms were monitoring Magnum’s share price and waiting for summer sales before deciding whether to move, people familiar with the matter told Reuters.
The read-through for Unilever was useful, but not clean. Magnum shares jumped nearly 16% after the Reuters report, yet the stock had traded close to 13 euros before the report, below a 16.5 euro high earlier this year and near its debut price after a December listing that valued the company at about 7.8 billion euros.
Analyst tone was less warm. Jefferies analyst David Hayes cut his Unilever target price to 37 pounds from 43 pounds and kept an Underperform rating, meaning he expects the stock to lag, according to an ABM FN-Dow Jones report carried by ING Markets. Hayes cited doubts about volume growth in 2026 and 2027, possible slowing U.S. sales trends and a lower mid-term growth view of about 3.5%, down from 4%.
The same report said Hayes saw Unilever moving closer to the playbook associated with activist investor Nelson Peltz: higher targets, cost cuts, big divestments and acquisitions meant to show growth. Hayes said he would revisit his negative stance only when acquisitions prove successful and investor worries ease, and he pointed to focus on the planned food-arm sale in the first half of 2027.
Unilever did not issue a new trading update on Monday. Its latest quarterly update, released on April 30, showed underlying sales growth of 3.8%, a measure that strips out currency moves and portfolio changes, ahead of a 3.6% company-compiled consensus; the company also kept its 2026 sales and margin targets.
The uncomfortable part is cost. Unilever said it expected full-year cost inflation of about 750 million to 900 million euros, including logistics and factory costs, and finance chief Srinivas Phatak said there would be “frequent price increases but in small doses.” Reuters
That leaves investors pricing a narrow trade-off: selling more units — volume growth — while raising prices without pushing shoppers to cheaper labels. Chris Beckett, a consumer staples analyst at Quilter Cheviot, said Unilever was constrained in developed Europe: “There are limits to what they can do – it’s not easy to take pricing.” Reuters
Competitive pressure is not abstract. Reuters said Nestle and Procter & Gamble had also warned of higher costs tied to the Iran war, while in ice cream, Magnum says it holds about 21% of the $87 billion global market, ahead of Froneri’s 11%; Froneri is backed by PAI Partners and Nestle.
But the risks are clear. JPMorgan analysts said tax constraints tied to Magnum’s tax-free demerger — a spin-off structured to avoid an immediate tax bill — made a takeover remote, and buyout firms are still waiting on summer sales. If costs stay high or U.S. demand weakens, Unilever’s shares could drift back toward the Jefferies downside case rather than benefit from Magnum speculation.
For now, Monday trade suggests investors are not chasing the break-up story. The shares remain well below the one-year high of 5,542.11 pence shown by MarketScreener, leaving each new disposal headline to compete with the simpler question of whether shoppers keep buying Dove, Vaseline and household products at higher prices.
